Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD…
この記事を読む
記事一覧 6ページ
この記事を読む
ロルラチニブとALKバリアント3
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Typ…
この記事を読む
免疫療法後は何をしても変わらない？
Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens…
この記事を読む
オシメルチニブとアファチニブ交替療法、耐性機序が興味深い
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single…
この記事を読む
肺炎のような粘液性肺腺癌の元は孤発型なのか？
Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics. Goto E et…
この記事を読む
T細胞エンゲ―ジャーは小細胞肺癌治療の新たな選択肢となるか？
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label…
この記事を読む
腫瘍治療電場療法、新たな希望か眉唾か
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-sm…
この記事を読む
トラスツズマブ・デルクステカンは減量でもなお肺臓炎の発症率が高い
Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Rand…
この記事を読む
MET Exon14に患者背景に特徴はあるか
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes. M…
この記事を読む
抗生物質と免疫チェックポイント阻害薬、まだまだ危うい
Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Canc…